Pooling 10 head-to-head studies against semaglutide, researchers found 4.28 points more weight loss on tirzepatide, though most of the data was observational.
Recap by typeshit. Full story at note.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
The advisory committee voted to return six peptides barred in 2023, over FDA staff objections. The author argues the GLP-1 shortage proved compounders can deliver.
A short lipidated peptide pulled Nav1.8 pain channels off nerve cell surfaces in a Cell Reports Medicine study. The company says several candidates are now in evaluation.
Loading…